Wilmington, DE, United States of America

Robert C DiLuccio

This inventor holds 2 USPTO granted patents. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1983-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 1983-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert C. DiLuccio

Introduction

Robert C. DiLuccio is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of transdermal drug delivery systems. With a total of 2 patents, his work has the potential to impact the way medications are administered.

Latest Patents

DiLuccio's latest patents include innovative pharmaceutical compositions for the transdermal delivery of opioids. These compositions are designed to effectively deliver a therapeutic dose of opioids to the systemic circulation of a mammal. The formulations consist of the opioid, a penetration enhancer, and a suitable pharmaceutical carrier, preferably propylene glycol. Another patent focuses on laminates of lamellar articles and polyolefins, which involves a unique laminate structure that combines a heterogeneous blend of polyolefin and a condensation polymer.

Career Highlights

Robert C. DiLuccio is currently associated with E.I. du Pont de Nemours and Company, a leading organization in the field of science and technology. His work at this company has allowed him to explore and develop innovative solutions in pharmaceutical applications.

Collaborations

DiLuccio has collaborated with various professionals in his field, including his coworker Bruce J. Aungst. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert C. DiLuccio's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving drug delivery systems. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…